Bottomed out: These 2 stocks with fantastic catch-up potential!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

According to a report from www.aktienwelt360.de, shares of Novozymes and NextEra Energy potentially have a lot of upside potential despite having lost a lot of value over the year. Novozymes, the world's largest enzyme manufacturer, recently recorded record results, but generated far less than in the previous year. The planned merger with Chr. Hansen has led to a decline in the share price, but the company expects new records in sales and net income as early as 2024 and 2025. The acquisition is expected to calm markets and further drive the company's growth. NextEra Energy, an American utility, has also lost significant value, although the company continues to post positive...

Gemäß einem Bericht von www.aktienwelt360.de, Die Aktien von Novozymes und NextEra Energy haben potenziell viel Aufholpotenzial, obwohl sie im Laufe des Jahres stark an Wert verloren haben. Novozymes, der weltweit größte Enzymhersteller, verzeichnete zuletzt ein Rekordergebnis, erwirtschaftete allerdings noch weit weniger als im Vorjahr. Der geplante Zusammenschluss mit Chr. Hansen hat zu einem Rückgang des Aktienkurses geführt, doch das Unternehmen erwartet bereits 2024 und 2025 neue Bestmarken bei Umsatz und Nettoergebnis. Die Akquisition dürfte die Märkte beruhigen und das Wachstum des Unternehmens weiter vorantreiben. NextEra Energy, ein amerikanischer Energieversorger, hat ebenfalls deutlich an Wert verloren, obwohl das Unternehmen weiterhin positive …
According to a report from www.aktienwelt360.de, shares of Novozymes and NextEra Energy potentially have a lot of upside potential despite having lost a lot of value over the year. Novozymes, the world's largest enzyme manufacturer, recently recorded record results, but generated far less than in the previous year. The planned merger with Chr. Hansen has led to a decline in the share price, but the company expects new records in sales and net income as early as 2024 and 2025. The acquisition is expected to calm markets and further drive the company's growth. NextEra Energy, an American utility, has also lost significant value, although the company continues to post positive...

Bottomed out: These 2 stocks with fantastic catch-up potential!

According to a report by www.aktienwelt360.de,

Novozymes and NextEra Energy shares potentially have a lot of upside potential, despite having lost a lot of value over the year. Novozymes, the world's largest enzyme manufacturer, recently recorded record results, but generated far less than in the previous year. The planned merger with Chr. Hansen has led to a decline in the share price, but the company expects new records in sales and net income as early as 2024 and 2025. The acquisition is expected to calm markets and further drive the company's growth.

NextEra Energy, an American utility, has also lost significant value despite continuing positive guidance and solid earnings growth. The downsizing of the gas business and the planned increase in the dividend could ensure positive development for the company in the long term.

Current prices potentially offer a favorable entry opportunity for investors who want to benefit from a catch-up movement. Given the positive outlook and current market conditions, both Novozymes and NextEra Energy could represent worthwhile investment opportunities in the near future.

Read the source article at www.aktienwelt360.de

To the article